Segment Information

9 Months Ended

Sep. 27, 2020

Segment Reporting [Abstract]

Segment Information

9. SEGMENT INFORMATION

We have one reportable segment, Core Illumina, as of September 27, 2020, which relates to Illumina’s core operations. Prior to the Helix deconsolidation on April 25, 2019, our reportable segments included both Core Illumina and Helix. See note “3. Investments and Fair Value Measurements” for further details.

Core Illumina:

Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina includes all of our operations, excluding the results of our previously consolidated VIE, Helix.

Helix:

Helix was established to enable individuals to explore their genetic information by providing affordable sequencing and database services for consumers through third-party partners, driving the creation of an ecosystem of consumer applications.

Core Illumina sells products and provides services to Helix in accordance with contractual agreements between the entities.

In millions	Q3 2020		Q3 2019		YTD 2020		YTD 2019
Revenue:
Core Illumina	$	794	$	907	$	2,286	$	2,591
Helix	—		—		—		1
Elimination of intersegment revenue	—		—		—		(1)
Consolidated revenue	$	794	$	907	$	2,286	$	2,591
Income (loss) from operations:
Core Illumina	$	162	$	308	$	447	$	740
Helix	—		—		—		(24)
Elimination of intersegment earnings	—		—		—		1
Consolidated income from operations	$	162	$	308	$	447	$	717